Skip to main content
Trials
Sponsors
Conditions
Drugs
Pricing
Trials
Sponsors
Conditions
Drugs
Pricing
Loading search results
Clinical Trials for "Cheol Lee, M.D.,Ph.D"
7
trials
Share
Relevance
ID
Status
Phase
Title
Sponsor
NCT01905566
Completed
Phase 4
Comparison of Clopidogrel Versus Ticagrelor Therapy for Atherosclerotic Plaque Inflammation
AstraZeneca
ClinicalTrials.gov
NCT01905566
Completed
Phase 4
Comparison of Clopidogrel Versus Ticagrelor Therapy for Atherosclerotic Plaque I...
AstraZeneca
NCT02105623
Terminated
Phase 4
EARly Prevention of aTHeroma Progression
CardioVascular Research Foundation, Korea
ClinicalTrials.gov
NCT02105623
Terminated
Phase 4
EARly Prevention of aTHeroma Progression
CardioVascular Research F...
NCT02378064
Completed
Phase 4
Comparison of Fimasartan Versus Amlodipine Therapy on Carotid PlaquE Inflammation
Boryung Pharmaceutical Co., Ltd
ClinicalTrials.gov
NCT02378064
Completed
Phase 4
Comparison of Fimasartan Versus Amlodipine Therapy on Carotid PlaquE Inflammatio...
Boryung Pharmaceutical Co...
NCT02494284
Terminated
Phase 4
Short-Term Dual Antiplatelet and Maintenance CloPidogrel Therapy After Drug-Eluting Stent Implantation
CardioVascular Research Foundation, Korea
ClinicalTrials.gov
NCT02494284
Terminated
Phase 4
Short-Term Dual Antiplatelet and Maintenance CloPidogrel Therapy After Drug-Elut...
CardioVascular Research F...
NCT02978456
Completed
Not Applicable
Quantitative Coronary Angiography Versus Intravascular Ultrasound GUIDancE for Drug-Eluting Stent Implantation
Biotronik SE & Co. KG
ClinicalTrials.gov
NCT02978456
Completed
Not Applicable
Quantitative Coronary Angiography Versus Intravascular Ultrasound GUIDancE for D...
Biotronik SE & Co. KG
NCT03208465
Completed
Phase 4
Empagliflozin Versus Sitagliptin Therapy for Improvement of Myocardial Perfusion Reserve in Diabetic Patients With Coronary Artery Disease
CHEOL WHAN LEE, M.D., Ph.D
ClinicalTrials.gov
NCT03208465
Completed
Phase 4
Empagliflozin Versus Sitagliptin Therapy for Improvement of Myocardial Perfusion...
CHEOL WHAN LEE, M.D., Ph....
NCT04330079
Terminated
Phase 4
Effects of dapaglifloziN Therapy on Myocardial Perfusion Reserve in Prediabetic Patients With Stable coronarY Artery Disease
CHEOL WHAN LEE, M.D., Ph.D
ClinicalTrials.gov
NCT04330079
Terminated
Phase 4
Effects of dapaglifloziN Therapy on Myocardial Perfusion Reserve in Prediabetic...
CHEOL WHAN LEE, M.D., Ph....
Result Breakdown
Status
Completed
4 (57%)
Terminated
3 (43%)
Phase
Phase 4
6 (86%)
not_applicable
1 (14%)
Top Conditions
Coronary Disease
3 (43%)
Coronary Artery Disease
2 (29%)
Plaque, Atherosclerotic
1 (14%)
Show 6 more
Top Sponsors
CHEOL WHAN LEE, M.D., Ph.D
7 (100%)
CardioVascular Research Foundation, Korea
3 (43%)
AstraZeneca
1 (14%)
Show 4 more
Start your search
Search over 500,000 clinical trials worldwide
Search
Expert
Popular:
Cancer
Diabetes
Alzheimer
COVID-19
Heart Disease